Jennison Associates LLC Makes New $1.04 Million Investment in Integer Holdings Corporation $ITGR

Jennison Associates LLC acquired a new stake in Integer Holdings Corporation (NYSE:ITGR) during the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 13,208 shares of the medical equipment provider’s stock, valued at approximately $1,036,000.

A number of other hedge funds have also modified their holdings of ITGR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Integer by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock worth $2,539,000 after buying an additional 837 shares during the period. Millennium Management LLC boosted its stake in Integer by 2,408.8% in the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock valued at $14,531,000 after buying an additional 118,224 shares in the last quarter. Jones Financial Companies Lllp grew its position in Integer by 79,888.9% in the first quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock valued at $850,000 after acquiring an additional 7,190 shares during the period. United Services Automobile Association bought a new stake in Integer in the first quarter valued at $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Integer by 4.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock worth $12,900,000 after acquiring an additional 4,873 shares in the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Trading Down 0.4%

Shares of ITGR opened at $83.69 on Monday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75. The company has a market cap of $2.85 billion, a price-to-earnings ratio of 20.87, a PEG ratio of 1.47 and a beta of 0.67. The stock has a fifty day moving average price of $86.07 and a two-hundred day moving average price of $81.46. Integer Holdings Corporation has a 52-week low of $62.00 and a 52-week high of $126.86.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 EPS for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a return on equity of 12.83% and a net margin of 7.64%.The business had revenue of $439.58 million for the quarter, compared to the consensus estimate of $426.48 million. During the same quarter in the previous year, the company posted $1.31 EPS. Integer’s revenue for the quarter was up .5% on a year-over-year basis. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Analysts predict that Integer Holdings Corporation will post 6.4 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on ITGR. Piper Sandler reissued an “overweight” rating and set a $97.00 price objective (up from $87.00) on shares of Integer in a report on Friday. Truist Financial upped their target price on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a report on Friday, February 20th. Weiss Ratings raised shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 24th. Citigroup reduced their price target on shares of Integer from $92.00 to $89.00 and set a “neutral” rating on the stock in a research report on Friday. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $101.00 price objective on shares of Integer in a research note on Monday, February 23rd. Four equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $98.29.

Integer News Roundup

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Piper Sandler reaffirmed an “overweight” rating and raised its price target to $97, signaling upside potential and institutional confidence in Integer’s longer‑term prospects. Piper Sandler Rating
• Positive Sentiment: Integer’s board initiated a strategic review (including potential sale, merger or other combinations) to maximize shareholder value — a catalyst that can unlock premium bids or strategic alternatives over time. Integer Strategic Review
• Positive Sentiment: Market commentary highlighted that revenue beat and strength across key product lines drove a positive market reaction despite an EPS miss, supporting confidence in top-line momentum. Zacks Coverage
• Neutral Sentiment: Several analysts updated forecasts after the Q1 release; revisions are mixed and reflect differing views on margin recovery and the impact of the strategic review. Analyst Revisions
• Neutral Sentiment: Trading in ITGR was briefly halted as news was released, which can increase intraday volatility but does not change fundamentals. Q1 Results Release
• Negative Sentiment: Q1 EPS was $1.20, missing consensus by $0.01 and down from $1.31 a year ago; management set FY26 EPS guidance of $5.83–$6.40, below the street consensus (~$6.49), which raises near‑term execution concerns. Earnings Details
• Negative Sentiment: Citigroup trimmed its price target from $92 to $89 and moved to a “neutral” rating, reflecting more cautious near‑term sentiment and limiting upside from that broker’s client base. Citigroup Note

Insider Buying and Selling

In other Integer news, VP Tommy P. Thomas sold 825 shares of the firm’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the sale, the vice president owned 4,381 shares in the company, valued at approximately $372,385. This trade represents a 15.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.10% of the stock is currently owned by corporate insiders.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.